edgen-logoBeta

Chatea con Ed

Invest

Brief

Desk
Otros

Noticias

Descubrir

Cartera
Misiones
Sigue nuestro

Únete a nuestro

EN
Atrás


healthcare: biotechNoticias

Para ustedMercadosEconomíaTecnología e IACriptomonedaEnergíaAtención médicaHong Kong y ChinaFinanzas

Farmacéutico

Biotecnología

Servicios de salud

Dispositivos médicos

Two gene-editing trial deaths in China expose oversight gaps

Two gene-editing trial deaths in China expose oversight gaps

Aug 07 2026, 04:38
Biogen closes RayThera deal adding Phase 1 immunology assets

Biogen closes RayThera deal adding Phase 1 immunology assets

Aug 06 2026, 22:31
FDA clears Replimune's melanoma drug after two rejections, 10-3 vote

FDA clears Replimune's melanoma drug after two rejections, 10-3 vote

Aug 06 2026, 20:39
Tarsus to buy Alkeus for $800 million in retina push

Tarsus to buy Alkeus for $800 million in retina push

Aug 06 2026, 12:35
Iovance posts record $99M Q2 revenue as Amtagvi demand triples awareness

Iovance posts record $99M Q2 revenue as Amtagvi demand triples awareness

Aug 06 2026, 11:36
Alphamab licenses JSKN016 to Pathos AI in $2.1 billion deal

Alphamab licenses JSKN016 to Pathos AI in $2.1 billion deal

Aug 04 2026, 01:02
BioNTech names Sobi's Oelkers as CEO, succeeding Sahin by 2027

BioNTech names Sobi's Oelkers as CEO, succeeding Sahin by 2027

Aug 03 2026, 10:24
Grail trades near $70 after Galleri trial failure erases $2.2B

Grail trades near $70 after Galleri trial failure erases $2.2B

Aug 01 2026, 17:48
GSK, Relation Therapeutics sign $110 million AI drug discovery deal

GSK, Relation Therapeutics sign $110 million AI drug discovery deal

Jul 30 2026, 09:53
J&J joins in vivo CAR-T race as pharma bets $14B on technology

J&J joins in vivo CAR-T race as pharma bets $14B on technology

Jul 29 2026, 21:52
Viking Therapeutics advances 3 obesity trials with $502M cash runway

Viking Therapeutics advances 3 obesity trials with $502M cash runway

Jul 29 2026, 20:34
uniQure targets Q3 2026 BLA submission after FDA accelerated-approval alignment

uniQure targets Q3 2026 BLA submission after FDA accelerated-approval alignment

Jul 29 2026, 18:08
Allogene's cema-cel clears 58% MRD rate, wins FDA RMAT and Fast Track

Allogene's cema-cel clears 58% MRD rate, wins FDA RMAT and Fast Track

Jul 29 2026, 12:54
Ocugen wins FDA RMAT designation for OCU410 targeting 2M GA patients

Ocugen wins FDA RMAT designation for OCU410 targeting 2M GA patients

Jul 29 2026, 11:20
Celcuity drops 18% as delayed drug launch disappoints analysts

Celcuity drops 18% as delayed drug launch disappoints analysts

Jul 29 2026, 00:10
Instinct Bio secures $150 million equity facility for regenerative medicine

Instinct Bio secures $150 million equity facility for regenerative medicine

Jul 28 2026, 14:12
Firefly and Next Health launch cognitive initiative after FDA backs 6 peptides

Firefly and Next Health launch cognitive initiative after FDA backs 6 peptides

Jul 28 2026, 12:19
Gossamer Bio surges 25% as FDA paves path for September NDA filing

Gossamer Bio surges 25% as FDA paves path for September NDA filing

Jul 27 2026, 18:47
Immunocore's Kimmtrak sales climb 29% as 2026 trial catalysts loom

Immunocore's Kimmtrak sales climb 29% as 2026 trial catalysts loom

Jul 27 2026, 17:12
Decoy Therapeutics D-MAV shows nanomolar activity against Ebola Zaire

Decoy Therapeutics D-MAV shows nanomolar activity against Ebola Zaire

Jul 27 2026, 13:16

Características
Copiloto de IA para Acciones y Criptomonedas
Predicción de precios
Seguimiento de Recaudación de Fondos
Comparación de Criptomonedas
Página de inicio
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
Términos de usoPolítica de privacidadMapa del sitio
© 2026 Edgen impulsado poredgen-logo